X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
alzheimer's disease (234) 234
neurology (217) 217
dementia (141) 141
neurosciences (128) 128
humans (120) 120
mild cognitive impairment (112) 112
index medicus (102) 102
aged (101) 101
clinical neurology (100) 100
female (95) 95
male (95) 95
biomarkers (94) 94
cerebrospinal fluid (77) 77
middle aged (74) 74
diagnosis (63) 63
magnetic resonance imaging (58) 58
clinical medicine (55) 55
klinisk medicin (48) 48
medical and health sciences (48) 48
medicin och hälsovetenskap (48) 48
neurologi (46) 46
aged, 80 and over (43) 43
alzheimers-disease (42) 42
neuropsychological tests (41) 41
mri (40) 40
cognitive ability (38) 38
risk factors (36) 36
biomarkers - cerebrospinal fluid (35) 35
alzheimer disease - diagnosis (34) 34
amyloid beta-peptides - cerebrospinal fluid (33) 33
disease progression (33) 33
alzheimer’s disease (32) 32
geriatrics & gerontology (32) 32
medical research (30) 30
national institute (30) 30
analysis (29) 29
geriatrics and gerontology (29) 29
prognosis (29) 29
studies (29) 29
tau (29) 29
alzheimers disease (28) 28
aging (27) 27
amyloid (27) 27
atrophy (27) 27
pathology (27) 27
psychiatry (27) 27
peptide fragments - cerebrospinal fluid (26) 26
psychiatry and mental health (26) 26
research (26) 26
tau proteins - cerebrospinal fluid (26) 26
biological markers (25) 25
cognition (25) 25
cohort studies (25) 25
neurodegenerative diseases (25) 25
alzheimer disease - cerebrospinal fluid (24) 24
impairment (23) 23
medicine, experimental (23) 23
prevalence (23) 23
recommendations (23) 23
brain (22) 22
dementia disorders (22) 22
follow-up studies (22) 22
neurovetenskaper (22) 22
age (21) 21
mci (21) 21
tau protein (21) 21
csf biomarkers (20) 20
memory (20) 20
apolipoproteins e - genetics (19) 19
usage (19) 19
clinical trials (18) 18
decline (18) 18
diagnostic-criteria (18) 18
epidemiology (18) 18
neuroimaging (18) 18
alzheimer disease - complications (17) 17
diagnostic guidelines (17) 17
hippocampus (17) 17
mental disorders (17) 17
neurodegeneration (17) 17
predictive value of tests (17) 17
progression (17) 17
alzheimer disease - diagnostic imaging (16) 16
alzheimer disease - pathology (16) 16
cerebrospinal-fluid biomarkers (16) 16
csf (16) 16
longitudinal studies (16) 16
risk (16) 16
alzheimer disease - genetics (15) 15
association workgroups (15) 15
cerebrospinal-fluid (15) 15
cognition disorders - diagnosis (15) 15
guidelines (15) 15
abridged index medicus (14) 14
apolipoprotein e (14) 14
medical imaging (14) 14
adult (13) 13
association (13) 13
cognitive dysfunction - cerebrospinal fluid (13) 13
criteria (13) 13
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet Neurology, ISSN 1474-4422, 2018, Volume 17, Issue 3, pp. 211 - 212
Journal Article
Brain, ISSN 0006-8950, 06/2018, Volume 141, Issue 6, pp. 1589 - 1591
Journal Article
Brain, ISSN 0006-8950, 2018, Volume 141, Issue 6, pp. 1589 - 1591
Journal Article
JAMA, ISSN 0098-7484, 06/2017, Volume 317, Issue 22, pp. 2285 - 2287
Journal Article
JAMA - Journal of the American Medical Association, ISSN 0098-7484, 06/2017, Volume 317, Issue 22, pp. 2285 - 2287
Journal Article
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, ISSN 1552-5260, 07/2017, Volume 13, Issue 7, pp. P178 - P179
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 06/2018, Volume 64, Issue s1, pp. S213 - S227
Increasing interest in clinical trials and clinical research settings to identify Alzheimer’s disease (AD) in the earliest stages of the disease has led to the... 
Pathology | Medical research | Clinical trials | Biomarkers | Risk analysis | Alzheimer's disease | Risk factors
Journal Article
Brain, ISSN 0006-8950, 06/2018, Volume 141, Issue 6, pp. 1589 - 1591
This scientific commentary refers to 'Brain properties predict proximity to symptom onset in sporadic Alzheimer's disease', by Vogel et al.... 
DEMENTIA | NEUROSCIENCES | CLINICAL NEUROLOGY
Journal Article
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, ISSN 1552-5260, 07/2019, Volume 15, Issue 7, pp. P1360 - P1360
Journal Article
Brain, ISSN 0006-8950, 12/2018, Volume 141, Issue 12, pp. 3443 - 3456
Abstract Alzheimer’s disease is a heterogeneous disorder. Understanding the biological basis for this heterogeneity is key for developing personalized... 
Journal Article
Journal of Neurology, Neurosurgery & Psychiatry, ISSN 0022-3050, 10/2011, Volume 82, Issue 10, pp. 1149 - 1156
Journal Article
Neurology, ISSN 0028-3878, 2019, Volume 92, Issue 23, pp. e2699 - e2705
OBJECTIVE: To identify potential predictors for outcome in individuals with mild cognitive impairment (MCI) who have reverted to normal cognition (NC).... 
Journal Article
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, ISSN 0022-3050, 10/2011, Volume 82, Issue 10, pp. 1149 - 1156
Background The identification of subjects with mild cognitive impairment (MCI) at high risk for Alzheimer's disease (AD) is important for prognosis and early... 
SYSTEMATIC REVIEWS | PHOSPHORYLATED-TAU | APOE GENOTYPE | ALZHEIMERS-DISEASE | MEMORY IMPAIRMENT | TEMPORAL-LOBE ATROPHY | CSF BIOMARKERS | QUESTIONABLE DEMENTIA | MILD COGNITIVE IMPAIRMENT | APOLIPOPROTEIN-E | SURGERY | PSYCHIATRY | CLINICAL NEUROLOGY | HEALTH-CARE
Journal Article
Journal of Alzheimer's Disease, ISSN 1387-2877, 2018, Volume 64, Issue 1, pp. S213 - S227
Increasing interest in clinical trials and clinical research settings to identify Alzheimer's disease (AD) in the earliest stages of the disease has led to the... 
cognition | biomarkers | neuronal injury | vascular risk | diagnosis | Amyloid | clinical trials | preclinical Alzheimer's disease | prognosis | lifestyle | VASCULAR RISK-FACTORS | ELDERLY INDIVIDUALS | CSF BIOMARKERS | CEREBROSPINAL-FLUID | TAU PATHOLOGY | NEUROSCIENCES | NORMAL OLDER-ADULTS | COGNITIVE DECLINE | AMYLOID-BETA DEPOSITION | PHYSICAL-ACTIVITY | BRAIN
Journal Article
Journal of the American Geriatrics Society, ISSN 0002-8614, 2019
OBJECTIVES: To study the interactive effect of white matter hyperintensities (WMH) and hippocampal atrophy on cognition in the oldest old. DESIGN: Ongoing... 
Journal Article
Alzheimer's & Dementia: The Journal of the Alzheimer's Association, ISSN 1552-5260, 2015, Volume 11, Issue 7, pp. P213 - P214
Journal Article
Neurobiology of Aging, ISSN 0197-4580, 06/2018, Volume 66, pp. 40 - 48
Cerebral white matter hyperintensities (WMHs) have been associated with vascular risk factors, both of which are under genetic influence. We examined in a... 
White matter hyperintensities | Clinical Neurology | b_open_article_in_toll_access_journal | Monozygotic twins | Ageing | Neuroscience(all) | Developmental Biology | Vascular risk factors | Geriatrics and Gerontology
Journal Article
Neurobiology of Aging, ISSN 0197-4580, 06/2018, Volume 66, Issue June, pp. 40 - 48
Cerebral white matter hyperintensities (WMHs) have been associated with vascular risk factors, both of which are under genetic influence. We examined in a... 
White matter hyperintensities | Clinical Neurology | Monozygotic twins | Ageing | Neuroscience(all) | Developmental Biology | Vascular risk factors | Geriatrics and Gerontology
Journal Article
Neurobiology of Aging, ISSN 0197-4580, 05/2019, Volume 77, pp. 58 - 65
Amyloid pathology in cognitively normal older adults has been associated with low memory performance and cognitive complaints, but findings are conflicting.... 
Clinical Neurology | Monozygotic twins | Ageing | Amyloid aggregation | Cognitive complaints | Neuroscience(all) | Memory performance | Developmental Biology | Geriatrics and Gerontology
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.